Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    0(0%)
    Results Posted
    0%(0 trials)

    Phase Distribution

    Phase 1
    1
    50%
    Phase 4
    1
    50%

    Phase Distribution

    1

    Early Stage

    0

    Mid Stage

    1

    Late Stage

    Phase Distribution2 total trials
    Phase 1Safety & dosage
    1(50.0%)
    Phase 4Post-market surveillance
    1(50.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    50.0%

    1 of 2 finished

    Non-Completion Rate

    50.0%

    1 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(1)
    Terminated(1)

    Detailed Status

    Completed1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 11 (50.0%)
    Phase 41 (50.0%)

    Trials by Status

    completed150%
    withdrawn150%

    Recent Activity

    0 active trials
    Showing 2 of 2
    completedphase_1

    Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery

    NCT05549492
    withdrawnphase_4

    Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block

    NCT03874806

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT05549492Phase 1

    Transversus Abdominis Plane Block With or Without Buprenorphine After Inguinal Hernia Surgery

    Completed
    NCT03874806Phase 4

    Pharmacokinetic Profile and Dermatomal Coverage of the Erector Spinae Plane Block

    Withdrawn

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2